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ABSTRACT
Single-cell mRNA sequencing (RNA-seq) methods
have undergone rapid development in recent years,
and transcriptome analysis of relevant cell popula-
tions at single-cell resolution has become a key re-
search area of biomedical sciences. We here present
single-cell mRNA 3-prime end sequencing (SC3-seq),
a practical methodology based on PCR amplification
followed by 3-prime-end enrichment for highly quan-
titative, parallel and cost-effective measurement of
gene expression in single cells. The SC3-seq allows
excellent quantitative measurement of mRNAs rang-
ing from the 10,000-cell to 1-cell level, and accord-
ingly, allows an accurate estimate of the transcript
levels by a regression of the read counts of spike-in
RNAs with defined copy numbers. The SC3-seq has
clear advantages over other typical single-cell RNA-
seq methodologies for the quantitative measurement
of transcript levels and at a sequence depth required
for the saturation of transcript detection. The SC3-
seq distinguishes four distinct cell types in the peri-
implantation mouse blastocysts. Furthermore, the
SC3-seq reveals the heterogeneity in human-induced
pluripotent stem cells (hiPSCs) cultured under on-
feeder as well as feeder-free conditions, demonstrat-
ing a more homogeneous property of the feeder-free
hiPSCs. We propose that SC3-seq might be used as a
powerful strategy for single-cell transcriptome anal-
ysis in a broad range of investigations in biomedical
sciences.
INTRODUCTION
Quantitative transcriptome analysis at single-cell reso-
lution is becoming an increasingly important area of
biomedical sciences, including in the research fields of
developmental/stem cell/cancer biology, and is providing
a foundation for understanding the regulation of gene ex-
pression in single cells in physiology or diseased states at a
systems level (1,2). Currently, single-cell mRNAs/cDNAs
need to be amplified prior to global quantitative assess-
ments. There have been two major approaches to the am-
plification of genes expressed in single cells: methods in-
volving exponential amplification by polymerase chain re-
action (PCR) and methods involving linear amplification
by T7 RNA polymerase (3,4). The methods involving ex-
ponential amplification have higher amplification efficiency,
greatermethodological simplicity and higher stability of the
amplified products, which allows an examination of the am-
plification quality prior to global measurements/repeated
assessment of the same single-cell transcriptomes. Accord-
ingly, these methods have been more prevalently used for
single-cell transcriptome analyses in practical experimental
settings (1,2,5,6).
To ensure quantitative/representative amplification of
single-cell cDNAs, one of the original methods that ap-
plied amplified cDNAs to global analyses using high-
density oligonucleotide microarrays restricted the length
of the first-strand cDNAs to, on average, ∼700 base pairs
(bp) from the 3-prime ends [transcription termination sites
(TTSs)] of mRNAs, by a short (5 min) reverse transcrip-
tion (7,8). Subsequently, this amplificationmethod has been
modified so that longer first-strand cDNAs including full-
length cDNAs are synthesized and the amplified products
can be applied to RNA sequencing (RNA-seq) analyses (9–
11). As an alternative approach, single-cell cDNA amplifi-
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cation protocols that enrich full-length cDNAs using ‘tem-
plate switching’ technology have also been applied to RNA-
seq analyses (12,13). In addition, to facilitate more abso-
lute quantification of transcript levels, methodologies that
tag the 5-prime [transcription start sites (TSSs)] or 3-prime
ends (TTSs) of the first-strand cDNAs/mRNAs in single
cells with unique molecular identifiers (UMIs) and amplify
cDNAs by exponential or linear amplification for RNA-
seq analyses have been reported (14–18). Finally, it has be-
come possible to simultaneously analyze the transcriptomes
of thousands of single cells by exploiting the barcodes that
distinguish these individual cells and by using microfluidics
to automatically capture and process them in large num-
bers; this, in turn, should open a pathway to clarification
of the comprehensive cellular decomposition of complex
tissues/organs (19,20).
Although the technology for single-cell transcriptome
analysis has thus been expanding rapidly, there remain a
number of issues that deserve careful consideration. For
example, synthesis of full-length cDNAs by reverse tran-
scription would not be an efficient process (9–11), template
switching technology would harbor inherent/stochastic er-
rors (12,13) and amplification of full-length cDNAs, espe-
cially those with longer length, by PCR would be suscepti-
ble to amplification bias (21). It should also be noted that
accurate quantification of expression levels by UMIs re-
quires a massive depth of sequence reads (17,20). Based on
these facts/considerations, we reason that amplification and
sequencing of the 3-prime ends of single-cell cDNAs would
provide more precise quantification of single-cell cDNAs
with a relatively small depth of sequence reads, allowing
a highly parallel analysis of a large number of single cells
in a broader range of more practical experimental settings.
We here report single-cell mRNA 3-prime end sequencing
(SC3-seq), a simple and practical methodology for highly
parallel and quantitative measurement of genes expressed
in single cells.
MATERIALS AND METHODS
Isolation of RNA/single cells for the SC3-seq analysis
All the animal experiments were performed under the eth-
ical guidelines of Kyoto University. The mouse embryonic
stem cell (mESC) line BVSC R8 was cultured as reported
previously (22), and total RNAs from the line were ex-
tracted using an RNeasy mini kit [Qiagen (74104), Hilden,
Germany] according to the manufacturer’s instructions.
The isolated RNAs were serially diluted by double-distilled
water (DDW) to concentrations of 250 ng/l, 25 ng/l, 2.5
ng/l, 250 pg/l and 25 pg/l for use in evaluation of the
quantitative performance of the SC3-seq.
For isolating mouse blastocysts, C57BL/6 mice were
mated and noon of the day when a copulation plug was
identified was designated as embryonic day (E) 0.5. At E4.5,
peri-implantation blastocysts were flushed from the uteri by
KSOM [MerckMillipore (MR-020P-5D), Darmstadt, Ger-
many], and then they were bisected into a polar part con-
taining an inner cell mass (ICM) and polar trophectoderm
(pTE) and a mural part containing mural TE (mTE) by a
glass needle under a dissectionmicroscope [LeicaMicrosys-
tems (M80), Wetzlar, Germany]. Each fragment was incu-
bated with 0.25% trypsin/phosphate buffered saline (PBS)
[Sigma-Aldrich (T4799), St. Louis, MO, USA] for around
10min at 37◦C, then dissociated into single cells by repeated
pipetting and dispersed in 0.1 mg/ml of PVA/PBS [Sigma-
Aldrich (P8136)] in preparation for the SC3-seq analysis.
The experimental protocols dealing with human subjects
were approved by the institutional review board (Ethics
Committee, Graduate School of Medicine, Kyoto Uni-
versity), with written informed consent provided by each
donor. For the analysis of human-induced pluripotent stem
cells (hiPSCs), the two iPSC lines, 585A1 and 585B1 (23),
were cultured either under a conventional culture condi-
tion [DMEM/F12 [Life Technologies (11330-32), Carls-
bad, CA, USA] supplemented with 20% (vol/vol) Knock-
out Serum Replacement [KSR; Life Technologies (10828-
028)], 1% (vol/vol) GlutaMax [Life Technologies (35050-
061)], 0.1-mM nonessential amino acids [Life Technologies
(11140-050)], 4-ng/ml recombinant human bFGF [Wako
Pure Chemical Industries (064-04541), Osaka, Japan] and
0.1-mM 2-mercaptoethanol [Sigma-Aldrich (M3148)]] on
the SNL feeder cells (24) or under a feeder-free condition as
reported previously (25,26). For the isolation of single hiP-
SCs cultured with the feeders, the culture was first treated
with CTK solutions [0.25% Trypsin [Life Technologies
(15090-046)], 0.1-mg/ml Collagenase IV [Life Technolo-
gies (17104-019)], 1-mM CaCl2 [Nacalai Tesque (06729-
55)]] (27) for the removal of the feeder cells, then dissoci-
ated into single cells using Accutase [Innovative Cell Tech-
nologies, San Diego, CA, USA]. For the preparation of sin-
gle cells from a feeder-free system, the cells were dissoci-
ated into single cells with 0.5 × TrypLE Select [TrypLE Se-
lect [Life Technologies (12563011)] diluted 1:1 with 0.5-mM
ethylenediaminetetraacetic acid/PBS] (25). Dissociated sin-
gle hiPSCs were transferred several times into a pick-up
medium consisting of 1% KSR/PBS containing 10 M of
the ROCK inhibitor Y-27632 [Wako Pure Chemical Indus-
tries (257-00511)] (24) in preparation for the SC3-seq anal-
ysis.
cDNA synthesis and amplification for the SC3-seq analysis
cDNA synthesis and amplification from isolated
RNAs/single cells were performed essentially as re-
ported previously (7,8), except that the Qiagen RNase
inhibitor [0.4 U/sample, Qiagen (129916)] and the Porcine
Liver RNase inhibitor [0.4 U/sample, Takara Bio (2311A)]
were used and that the spike-in RNAs developed by the
External RNA Controls Consortium [ERCC; Life Tech-
nologies (4456740)] were used and different numbers of
PCR cycles were employed for amplification depending on
the amounts of starting total RNAs (total RNA 100 ng:
seven cycles; 10 ng: 11 cycles; 1 ng: 14 cycles; 100 pg: 17
cycles; 10 pg: 20 cycles). A total of 62 316 or 12 463 copies
of the ERCC spike-in RNAs were added to the Lysis buffer
(7) per 10 pg of total RNAs and single cells, respectively
(see Supplementary Table S2 for the copy numbers of the
ERCC spike-in RNAs). Prior to the construction of the
SC3-seq library, the quality of the amplified cDNAs was
evaluated by examining the Ct values of the quantitative
real-time PCR (Q-PCR) of the ERCC spike-in RNAs (for
mouse ESC total RNA dilution analysis: ERCC-00074,
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9030 copies; ERCC-00004, 4515 copies; ERCC-00113,
2257 copies; ERCC-00136, 112.8 copies; ERCC-00042,
282.2 copies; ERCC-00095, 70.5 copies; ERCC-00019,
17.6 copies; and ERCC-00154: 4.4 copies; for the anal-
yses of mouse pre-implantation embryos and hiPSCs:
ERCC-00096: 1806 copies; ERCC-00171: 451.5 copies;
ERCC-00111: 56.4 copies) and several endogenous genes
(see Supplementary Table S3 for the primer list), and by
examining the cDNA fragment proportion by LabChip
GX [Perkin Elmer, Waltham, MA, USA] or Bioanalyzer
2100 [Agilent Technologies, Palo Alto, CA, USA].
Quantitative real-time PCR analysis (Q-PCR)
Q-PCR was performed using Power SYBR Green PCR
Master mix [Life Technologies (4367659)] with a CFX384
real-time qPCR system [Bio-Rad, Hercules, CA, USA] ac-
cording to the manufacturer’s instructions. The primer se-
quences are listed in Supplementary Table S3. Most of the
primer sets were designed using Primer-Blast (NCBI)within
a distance of 500 base pairs (bp) from the TTSs.
Library construction for the SC3-seq for the SOLiD 5500XL
system
Five nanogram of amplified and quality-checked cDNAs
were added to the pre-amplification buffer [1 × ExTaq
buffer [Takara Bio (RR006), Shiga, Japan], 0.2 mM of each
dNTP [TakaraBio (RR006)], 0.01g/l of theN-V3 (dT)24
primer (HPLC-purified, attachment of amine at the 5-prime
end), 0.01 g/l of the V1(dT)24 primer (HPLC-purified)
and 0.025 U/l of ExTaqHS [Takara Bio (RR006)]], and
were amplified by four cycles of PCR. The surplus primers
and PCR byproducts such as primer dimers were removed
by size selection through three rounds of purification us-
ing a 0.6 × volume of AMPureXP beads for each round
[Beckman Coulter (A63881), Tokyo, Japan] according to
the manufacturer’s instructions. The purified cDNAs were
diluted to 130l by DDWand fragmented by shearing with
Covaris S2 or E210 (duty cycle: 20%; intensity: 5; cycles per
burst: 200; duration: 50 s; an intensifier was installed in the
case of E210) [Covaris, Woburn, MA, USA] and then end-
polished in the End-polish buffer [1×NEBnext EndRepair
Reaction buffer [NEB (B6052S), Ipswich, MA, USA], 0.01
U/l of T4 DNA polymerase [NEB (M0203)] and 0.033
U/l of T4 polynucleotide kinase [NEB (M0201)]] for 30
min at 20oC. After incubation, a 0.8 × volume of the AM-
PureXP was immediately added, the solution was mixed
for more than 20 min and then the supernatant was trans-
ferred to a 1.2 × volume of the AMPureXP reagent and
the cDNAs were purified. Next, to provide the purified cD-
NAs with an Int-adaptor sequence, the cDNAs were incu-
bated in 30 l of the Internal adaptor extension buffer [1
× ExTaq Buffer, 0.23 mM of each dNTP, 0.67 M of the
IntV1 (dT)24 primer (HPLC-purified), 0.033 U/l of Ex-
TaqHS] using the following thermal cycler program: 95oC
for 3 min; 67oC for 2 min; and 72oC for 2 min. The reac-
tions were terminated by chilling in an ice-block, and after
the addition of 20 l of the P1-adaptor ligation buffer [a
mixture of 10 l of 5 × NEBNext Quick Ligation Reac-
tion Buffer [NEB (B6058S)], 0.6 l of 5 M of the P1-T
adaptor [Life Technologies (4464411)] and 1 l of T4 lig-
ase [NEB (M0202M)]], the solution was incubated for 15
min at 20oC and for 20 min at 72oC. After two rounds of
cDNA purification by adding a 1.2 × volume of AMPure
XP, the cDNAs were added into the Final amplification
buffer [1 × ExTaq buffer, 0.2 mM of each dNTP, 1 M of
the P1 primer, 1Mof the BarT0XX IntV1 primer (HPLC-
purified), 0.025 U/l of ExTaqHS] and amplified by PCR
using the following thermal cycler program: 95oC for 3 min;
followed by nine cycles of 95oC for 30 s, 67oC for 1 min
and 72oC for 1 min; with a final extension of 72oC for 3
min. Finally, the cDNA libraries were purified two times
by using a 1.2 × volume of AMPureXP and dissolved in
20 l of TE buffer. The quality and quantity of the con-
structed libraries were evaluated by LabChip GX or Bio-
analyzer 2100, a Qubit dsDNA HS assay kit [Life Tech-
nologies (Q32851)] and a SOLiD Library TaqMan Quan-
titation kit [Life Technologies (4449639)]. The clonal am-
plification of the libraries on beads by emulsion PCR (em-
PCR) was performed using SOLiDTM EZ BeadTM System
[Life Technologies (4449639)] at the E120 scale according to
the manufacturer’s instruction. The resulting bead libraries
were loaded into flowchips and sequenced for 50 bp and 5-
bp barcode plus Exact Call Chemistry (ECC) on an SOLiD
5500XL system [Life Technologies (4449639)].
Mapping of the raw reads to the reference genome
All the reads were surveyed and the adaptor or the poly-A
sequences were trimmed by cutadapt-1.3 (28). The trimmed
reads with less than 30 bp were discarded. The adaptor and
the poly-A sequences were observed in ∼1–20% and 5% of
the total reads, respectively. Untrimmed and trimmed reads
of 30 bp or longer were mapped onto the mouse genome
mm10 and the ERCC spike-in RNA sequences with tophat-
1.4.1/bowtie1.0.1 with the ‘––no-coverage-search’ option
(29).Mapped reads on the genome and the ERCCwere sep-
arated, and the reads on the genomewere converted into the
expression levels by cufflinks-2.2.0 using the ‘––compatible-
hits-norm’, ‘––no-length-correction’ and ‘––library-type fr-
secondstrand’ options and mm10 reference gene annota-
tions with extended TTSs (30). We also set the cufflinks op-
tion ‘––max-mle-iterations’ to 50 000, because default it-
erations (5000) resulted in ‘FAILED’ when estimating the
expression levels of some genes. For the reference gene an-
notations used in cufflinks, we extended the TTSs of the
reference genes up to 10 kb downstream to correctly esti-
mate the expression levels of genes whose transcripts are
longer than the reference toward the 3 prime. To estimate
the transcript copy number per cell, the ERCC spike-in
RNA reads were normalized to reads per million-mapped
reads (RPM) by total mapped reads on the genome used
for gene expression analysis. Mapped reads were visualized
using igv-2.3.34 (31). We confirmed that the conversion of
the mapped reads into the expression levels by HTSeq-0.6.0
(32) gave similar results to that by cufflinks-2.2.0 using the
described options (data not shown).
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Data analysis for the performance of the SC3-seq and the
other published methodologies
Analysis was performed using R software version 3.0.2
and Excel (Microsoft). The expression data by the SC3-
seq were analyzed using log2 (RPM+1) as the expression
value, except in Figure 4 and Supplementary Figure S4A
and B. In Figure 4, the RPM/FPKM values less than 0.01
were set as 0.01 for the calculation of correlation coeffi-
cients (13,33,34). In Supplementary Figure S4A and B, the
RPM/FPKMvalues less than 0.1 were set as 0.1 for the cal-
culation of correlation coefficients (13).
The estimation of the optimum definition of the 3-prime
ends of the transcripts was performed by modifying the ref-
erence gene annotation gff3 file. We calculated all gene ex-
pression values when the definition of the 3-prime ends of
the transcripts was extended in 1-kb increments up to 10 kb,
then in 10-kb increments up to 100 kb. Genes whose expres-
sion levels were increased by 10, 20, 30, 40, 50, 80, 100, 200
and 300% were counted.
The estimation of the approximate copy numbers per 10
pg total RNAs was performed by drawing a single linear
regression line for all log2 (RPM+1) values of the ERCC
spike-in RNAs (excluding the ERCC spike-in RNAs whose
copy numbers are lower than 100 copy per 10-pg RNAs and
the two outliers ERCC-00116 and ERCC-00004) in all the
32 amplified samples as a function of their copy numbers.
The approximate log2 (RPM+1) values for 1000 copies, 100
copies, 10 copies and one copy per 10 pg total RNA were
11.78, 8.10, 4.43 and 0.76, respectively.
The coverage is defined by the number of genes de-
tected in samples amplified from 10 pg of total RNAs [log2
(RPM+1) 1] as a percentage of that in samples amplified
from 100 ng of total RNAs [log2 (RPM+1)1] for different
expression-level ranges. Accuracy is defined based on the
number of genes detected in samples amplified from 100 ng
of total RNAs [log2 (RPM+1)1] as a percentage of that in
samples amplified from 10 pg of total RNAs [log2 (RPM+1)
1]. The truly expressed genes were defined as those that
were detected [log2 (RPM+1)1] in both samples prepared
by SC3-seq from 100 ng of RNAs. Multiple sample analy-
ses (eight samples) for the coverage and the accuracy were
performed by calculating the coverage and accuracy under
definitions of detection where 1 to 8 of the eight ampli-
fied samples exhibited reads.
For analysis of the saturation of the detection of gene
expression, conversion of the mapped reads to gene-
expression levels by cufflinks was repeated with the number
of mapped reads reduced to as low as 10 000. The num-
bers of genes detected at significant expression levels [log2
(RPM+1)> 4] were counted under different numbers of to-
tal mapped reads. When comparing the data by the SC3-
seq with the published data by the other methodologies, we
used log2 RPM as an expression value for the SC3-seq and
included the top 6555th and 6217th genes for mice and hu-
mans, respectively, (1/4 of all the annotated transcripts for
mice and humans) for the analysis.
Data analysis of the SC3-seq results for the single cells in the
mouse E4.5 blastocysts and hiPSCs
Analysis was performed using R software version 3.1.1
with the gplots and the qvalue packages, and EXCEL (Mi-
crosoft). All the analyses of expression data were performed
using log2 (RPM+1) values. Genes whose log2 (RPM+1)
value was less than 4 (less than ∼20 copies/cell) in all sam-
ples were excluded from the analysis. Unsupervised hier-
archical clustering (UHC) was performed using the hclust
function with Euclidean distances and Ward distance func-
tions (ward.D2). The principal component analysis (PCA)
was performed using the prcomp function without scaling.
To identify differentially expressed genes (DEGs) among
multi-groups, the oneway analysis of variance (ANOVA)
and the qvalue function were used for the calculation of the
P value and false discovery ratio (FDR), respectively. The
DEGs were defined as those exhibited a more than 4-fold
change between the samples (FDR < 0.01), and the mean
of the expression level of the group was  log2 (RPM+1)
= 4. The gene ontology (GO) analysis was performed using
the DAVID web tool (35).
Immunofluorescence analysis of mouse E4.5 embryos
For whole-mount immunofluorescence (IF) analysis, iso-
lated embryos were fixed in 4% paraformaldehyde in PBS
for 20min at room temperature, washed in 2%bovine serum
albumin (BSA)/PBS and incubated in the permeabiliza-
tion solution (0.5% Triton X/1.0% BSA/PBS) for 20 min
at room temperature. After washing twice in 2% BSA/PBS,
embryos were incubated with primary antibodies in 2%
BSA/PBS overnight at 4%, washed three times with 2%
BSA/PBS, incubated with secondary antibodies and 4,6-
diamidino-2-phenylindole (DAPI) in 2% BSA/PBS for 1 h
at room temperature, washed three timeswith 2%BSA/PBS
andmounted in VECTASHIELDMountingMedium [Vec-
tor Laboratories, (H-1000)]. The primary antibodies used
were as follows: anti-mouse NANOG [rat monoclonal;
eBioscience, (eBio14-5761)], anti-mouse POU5F1 [mouse
monoclonal; Santa Cruz, (sc-5279)], anti-mouse GATA4
[goat polyclonal; Santa Cruz, (sc-1237)], anti-mouse CDX2
[rabbit monoclonal, clone EPR2764Y; Abcam, (ab76541)].
The secondary antibodies used were as follows: Alexa
Fluor 488 anti-rat IgG [Life Technologies (A21208)], Alexa
Fluor 555 anti-rabbit [Life Technologies (A31572)], Alexa
Fluor 568 anti-mouse IgG [Life Technologies (A10037)]
and Alexa Fluor 647 anti-goat IgG [Life Technologies
(A21447)] (all donkey polyclonal). Image data were ob-
tained and processed by a confocal microscope [Olympus,
(FV1000)].
RESULTS
Design and establishment of the SC3-seq
We have previously reported a method for the amplification
of single-cell cDNAs enriched in the 3-prime ends (687 ±
279 bp) for high-density oligonucleotide microarray anal-
ysis (7,8). The method has been successfully used for the
analysis of diverse biological processes, including the iden-
tification of cell-type heterogeneity/specification in mouse
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blastocysts (7,36), the identification of transcriptome dy-
namics during the specification and development of pri-
mordial germ cells (37) and the identification of neuronal
subtypes during cerebellar cortex development (38). The
method has been shown to be powerful not only for the
transcriptome analysis of single cells but also for cells in the
range of several hundred to thousands (22,39). The method
has subsequently been modified so that longer cDNAs in-
cluding full-length cDNAs are synthesized and analyzed by
RNA-seq (9–11). However, considering the inefficiency of
full-length cDNA synthesis and susceptibility to amplifica-
tion bias of longer cDNAs, amplification and sequencing
of the 3-prime ends of cDNAs should provide more precise
assessment of gene-expression levels (Figure 1A). Further-
more, sequencing of only the 3-prime ends theoretically re-
quires a much smaller sequence depth for saturation (Fig-
ure 1B), making the analysis more cost-effective.
We therefore set out to design and establish a method-
ology that amplifies and sequences the 3-prime ends of
cDNAs synthesized from single cells, which we designate
the SC3-seq (Single-cell mRNA 3-prime end sequencing)
method (Figure 1C). For the amplification of cDNAs, we
adopt essentially the same methodologies we reported pre-
viously, which amplify cDNAs from single cells/single-cell
level RNAs in a highly representative manner (7,8) (Fig-
ure 1C). The first-strand cDNAs are synthesized by the V1
(dT)24 primer, the excess V1 (dT)24 primer and the annealed
mRNAs are digested by Exonuclease I and RNaseH, re-
spectively, the poly (dA) tail is added at the 3-prime ends
of the first-strand cDNAs, the second-strand cDNAs are
synthesized by the V3 (dT)24 primer and the resultant cD-
NAs are amplified by the V1 (dT)24 and V3(dT)24 primer
pair by a number of PCR cycles depending on the amount
of the starting materials (20 cycles for single cells or 10 pg
of total RNA). For the construction of the library for se-
quencing by the SOLiD sequencer, we design a procedure
that enriches the very 3-prime ends of the cDNAs bearing
the V1(dT)24 primer (Figure 1C and Supplementary Fig-
ure S1A). The amplified cDNAs are tagged by the NH2-
V3(dT)24 primer with a few PCR cycles, the primer dimers
are removed by three rounds of purification by AMPureXP
and the tagged cDNAs are fragmented by sonication, end-
polished and size-fractionated by sequential purification by
AMPure XP. The resultant cDNAs of ∼200–250 bp in size
are denatured, annealed by the IntV1(dT)24 primer for the
capture of the 3-prime ends with the extension of the in-
ternal adaptor extension sequence, ligated and sequence-
extended with the P1 adaptor and processed for final ampli-
fication by the P1 primer and the BarT0XX-IntV1 primer
bearing 96 distinct barcodes (a larger number of barcodes
can be provided if desired). The final amplified products are
sequenced from the P1-adaptor end, resulting in the map-
ping of the very 3-prime ends of themRNAs on the genomic
loci. Since the SC3-seq provides sequence reads only at the
very 3-prime ends of mRNAs, the absolute read counts be-
come proportional to the expression levels of mRNAs irre-
spective of their entire length, allowing simple and more ac-
curate quantification of the gene-expression levels. Normal-
ization by sequence reads per million-mapped reads should
thus provide an accurate quantification.
To examine the performance of the SC3-seq, we made a
dilution series of total RNAs [100 ng (10 000-cells level),
two replicates; 10 ng (1000-cells level), two replicates; 1 ng
(100-cells level), four replicates; 100 pg (10-cells level), eight
replicates; and 10 pg (single-cell level), 16 replicates] isolated
from mESCs, and, using these RNAs together with a set of
external spike-in RNA controls developed by the External
RNA Controls Consortium (ERCC), amplified (7, 11, 14,
17 and 20 initial PCR cycles for 100 ng, 10 ng, 1 ng, 100 pg
and 10 pg total RNAs, respectively) and sequenced them
by the SC3-seq. We confirmed by quantitative (Q)-PCR
that the ERCC spike-in RNAs were amplified highly pro-
portionally to their spiked-in copy numbers during the ini-
tial cDNA amplification (Supplementary Figure S1B) and
that the representation of a number of genes expressed in
ESCs (Supplementary Table S3) in the final cDNA library
just prior to sequencing is essentially identical to that in
the initially amplified cDNAs (Supplementary Figure S1C),
demonstrating the preservation of the representation of the
gene contents during both the cDNA amplification and li-
brary construction processes for the SC3-seq.
Figure 1D shows the averaged sequence read distribu-
tion of one of the amplified products of the 100-ng RNAs
by the SC3-seq (∼40–50% mapping efficiency; Supplemen-
tary Table S1). In good agreement with the design of SC3-
seq, the mapped reads were highly enriched at the very 3-
prime ends (∼150 bp upstream from the TTSs) of nearly all
mapped RefSeq genes, including non-coding RNAs (Sup-
plementary Figure S2). We found minor enrichment of the
mapped reads on the anti-sense strands of exons as well,
which would in part represent amplification products in
which theV1 (dT)24 primerwasmis-annealed to the 5-prime
ends of cDNAs for amplification (Figure 1C). For exam-
ple, the SC3-seq track around the Pou5f1 locus exhibited a
single clear peak corresponding to the very 3-prime end of
the sense strand of Pou5f1, with several minor peaks on the
anti-sense strand of the exons (Figure 1E). We also found
that, for a fraction of genes, the peaks of the SC3-seq reads
were observed downstream of the 3-prime ends of anno-
tated RefSeq transcripts, suggesting that these loci corre-
spond to the ‘bona fide’ 3-prime ends of the upstream tran-
scripts (Figure 1D andE). For example, for theNanog locus,
the SC3-seq peaks were observed∼ 1 kb downstream of the
annotated 3-prime end ofNanog (Figure 1E). Indeed, exam-
ination of the published RNA-seq data for a large amount
of RNAs of mESCs with massive sequence depth (33) iden-
tifies the same peak contiguous to the peaks of the upstream
exons ofNanog (Figure 1E), indicating that the 3-prime end
peaks detected by the SC3-seq belong toNanog transcripts.
This finding led us to re-define the 3-prime ends of a fraction
of the RefSeq transcripts. We examined the correlation be-
tween the extent of in silico extension of the TTSs of theRef-
Seq transcripts and the gene numbers that show an increase
in mapped reads by the SC3-seq. As shown in Figure 1F,
the number of genes that exhibited the increase of mapped
reads was increased by the extension of the definition of the
TTSs from the annotated TTSs, and ∼450 genes exhibited
the increase of their mapped reads by the extension of the
definition of the TTSs by 10 kb. We inspected the 205 genes
that exhibited gene counts of  2-fold (×2, ×3, ×4 in Fig-
ure 1F) by extending the definition of the TTSs by 10 kb in
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Figure 1. Establishment of the SC3-seq. (A) Concept of the SC3-seq. Synthesis and amplification of full-length cDNAs by reverse transcription (RT) and
PCR, respectively, are not efficient processes due to a number of potential limitations in RT and PCR. The SC3-seq targets only the 3-prime ends of the
transcripts (orange dotted square), which are more faithfully/quantitatively reverse-transcribed and amplified by RT and PCR, respectively, which in turn
will lead to a more quantitative outcome of the sequence reads for all genes. (B) 21 254 protein-coding genes annotated in the Mouse mm10 database are
aligned in the order of the length of their longest transcripts. While the sum of all the longest transcript lengths is around 60 Mbp, that of the 200 bp from
the 3-prime ends of all transcripts is only around 4Mbp, allowing sequence saturation at much smaller sequence depth. (C) Scheme for the SC3-seq, which
consists of (left) cDNA synthesis and amplification, and (right) library construction. In the first step (left), V1 (green) and V3 (gray) tags are added at the 3-
and 5-prime ends of cDNAs, respectively, as reported previously (7,8). In the second step (right), tags for the SOLiD sequencing (P1 tag, light blue; P2 tag,
dark blue; Internal adaptor, red; index for multiplexing, yellow) were added sequentially as depicted. The 3-prime ends of the cDNAs are captured in the
Internal adaptor extension step. See the Materials and Methods section and Supplementary Figure S1A for more details. (D) The averaged SC3-seq track
[read density (RPM,×1000 reads) plotted against the read position from the annotated TTSs] of 100 ng (10 000-cell level) of total RNAs frommESCs. The
red line represents the track of reads mapped on the sense strands; the blue line shows the track of reads mapped on the anti-sense strands. (E) The SC3-seq
reads of the Pou5f1 andNanog loci. The red peaks indicate the reads mapped on the sense strands; the blue peaks show the reads mapped on the anti-sense
strands. The orange peaks are the reads mapped by Ohta et al. (33). (F) Gene counts showing the increase in the number of reads as indicated by the color
code plotted against the extent of the definition of the 3-prime end extension. (G) Gene counts for correct (black bars) or wrong (gray gars) annotations
by the extension of the definition of the TTSs by the indicated length. The 205 genes that exhibited gene counts of 2-fold (×2, ×3, ×4 in Figure 1F) by
extending the definition of the TTSs by 10 Kb were visually inspected for collect/wrong annotations in comparison to the published RNA-seq data (33).
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comparison to the published RNA-seq data (33) and found
that in mESCs, while the extension by 10 kb indeed recov-
ered primarily correct gene counts, the extension by more
than 10 kb resulted in primarily incorrect annotations (Fig-
ure 1G). We therefore decided to define the peaks detected
within 10 kb downstream from the annotated TTSs as in-
dicating the expression of their immediate up-stream genes
and to analyze the SC3-seq data accordingly.
Evaluation of the quantitative performance of the SC3-seq
Reproducibility of the SC3-seq. To evaluate the quantita-
tive performance of the SC3-seq, we first analyzed the cor-
relation between the threshold-cycle (Ct) values by quanti-
tative (Q)-PCR of a number of genes in amplified cDNAs
from 1 ng (100-cell level, four replicates) and 10 pg (1-cell
level, 16 replicates) of total RNAs and the SC3-seq reads
[log2 (RPM+1)] of the same set of genes in the library pre-
pared from the same cDNAs. As shown in Figure 2A, re-
markably, the Ct values and the SC3-seq reads exhibited su-
perb correlations for both cDNAs (R2 = 0.9858 and 0.9428
for representative cDNAs from 1-ng and 10-pg RNAs, re-
spectively). Consistently, the SC3-seq reads [log2 (RPM+1)]
of the ERCC spike-in RNAs in amplified libraries of all di-
lution series correlated highly proportionally to their orig-
inal copy numbers (Figure 2B and Supplementary Figure
S3A; see Supplementary Table S2 for the copy numbers of
ERCC spike-in RNAs provided per 10 pg total RNAs in
each dilution), although the spike RNAs that provided less
than∼30 copies in 10-pg RNAs exhibited somewhat less ef-
ficient amplification. This makes it possible to estimate the
copy number per 10-pg RNAs of a gene from its SC3-seq
read number.
The scatter-plot analyses indicated that independent
samples amplified from 100 ng (10 000 cell-level, two repli-
cates), 10 ng (1000 cell-level, two replicates) and 1 ng (100
cell-level, four replicates) RNAs exhibited excellent corre-
lations (R2 = 0.995, 0.992, 0.988, respectively), with nearly
all the genes plotted within the 2-fold difference lines (Fig-
ure 2C and G and Supplementary Figure S3B and C). The
samples amplified from 100 pg (10-cell level, eight repli-
cates) RNAs also showed very good correlations (min R2–
max R2 = 0.940–0.945), with 89.6 and 97.8% of genes in a
representative pair-wise comparison (all expression ranges)
plotted within the 2- and 4-fold difference lines, respectively
(Figure 2C and G and Supplementary Figure S3B and C).
The samples amplified from 10 pg (1-cell level, 16 repli-
cates) RNAs exhibited good correlations (min R2–max R2
= 0.677–0.708), with 77.6 and 86.1% of genes in a represen-
tative pair-wise comparison (all expression ranges) plotted
within the 2- and 4-fold difference lines, respectively (Fig-
ure 2C and G and Supplementary Figure S3B and C). We
noted that independently amplified samples showed better
correlations for genes that are expressed more than ∼20
copies per 10 pg of RNAs, and particularly for those am-
plified from 10 pg of RNAs, with min R2–max R2 = 0.747–
0.786, and with 85.4 and 99.6% of genes in a representa-
tive pair-wise comparison plotted within the 2- and 4-fold
difference lines, respectively (Figure 2C and G and Supple-
mentary Figure S3B and C).
When compared to the sequence profiles of samples am-
plified from 100 ng (10 000 cell-level) of RNAs, samples am-
plified from 10 ng (1000 cell-level), 1 ng (100 cell-level) and
100 pg (10-cell level) of RNAs exhibited very good correla-
tions (min R2–max R2 = 0.991–0.993, 0.987–0.989, 0.961–
0.964, respectively), and those amplified from 10 pg (1-cell
level) RNAs showed good correlations (min R2–max R2
= 0.776–0.797), with 75 and 87% of genes in a represen-
tative pair-wise comparison (all expression ranges) plotted
within the 2- and 4-fold difference lines, respectively (Fig-
ure 2D and G and Supplementary Figure S3B and C). For
genes that are expressed more than ∼20 copies per 10 pg
of RNAs, samples amplified from 10 pg (1-cell level) RNAs
showed better correlations (minR2–maxR2 = 0.789–0.825),
with 90.8 and 99.9% of genes in a representative pair-wise
comparison plotted within the 2- and 4-fold difference lines,
respectively (Figure 2D and G and Supplementary Figure
S3B and C).
To evaluate the performance of the SC3-seq for 1-cell
level RNAs further, we compared the log-averaged expres-
sion levels in two samples amplified from 100 ng of RNAs
with those in eight samples amplified from 10 pg of RNAs.
The scatter-plot analysis showed that the averaged samples
exhibited a better correlation (R2 = 0.929), with 79.8 and
97% of genes (all expression ranges) plotted within the 2-
and 4-fold difference lines, respectively (Figure 2E). For
genes that are expressed more than ∼20 copies per 10 pg
of RNAs, they showed a good correlation (R2 = 0.922),
with 98.6 and > 99.9% of genes plotted within the 2- and
4-fold difference lines, respectively, and exhibited relatively
small standard deviations (SDs) of expression levels (Fig-
ure 2E and F). Collectively, these findings demonstrate the
highly quantitative performance of the SC3-seq for RNAs
ranging from 100 ng (10 000-cell level) to 10 pg (1-cell
level). Based on these results, we estimated the number of
mRNA molecules present in 10 pg (1-cell level) of mESC
total RNAs as∼300 000 (Figure 2H), a value in good agree-
ment with previous findings (1,16).
Coverage and accuracy by the SC3-seq. To examine the
performance of the SC3-seq further, we next evaluated the
coverage [the number of genes detected in 10-pg RNAs
(log2 (RPM+1) 1)/the number of genes detected in 100-
ng RNAs (log2 (RPM+1)1)] and accuracy [the number of
genes detected in 10-pg RNAs (log2 (RPM+1) 1) that are
detected in 100-ng RNAs (log2 (RPM+1) 1)] of the SC3-
seq from 10-pg RNAs by using the data from eight repli-
cates. The truly expressed genes were defined as those that
were detected [log2 (RPM+1)1] in both samples prepared
by SC3-seq from 100 ng of RNAs. Coverage of the single
amplified samples as a function of the expression level was
plotted (black squares in Figure 3A). As expected from the
previous reports (7) and the data shown above (Figure 2),
coverage was dependent on the expression level, but a vast
majority of the truly expressed genes (cumulative percent-
age, 94.1%) that are expressed more than 10 copies per 10
pg were successfully detected (Figure 3A). The accuracy of
the single amplified samples was plotted similarly, and we
found that 99.7% (cumulative percentage) of the genes de-
tected were truly expressed in the expression level range of
more than 10 copies per 10-pg RNAs (Figure 3B). When
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Figure 2. Quantitative performance of the SC3-seq. (A) Comparison of the expression levels of the genes listed in Supplementary Table S3 in amplified
cDNAs [from 1 ng (left, four replicates) and 10 pg (right, 16 replicates) total RNAs, prior to the SC3-seq library construction] estimated by Q-PCR (raw Ct
value) with those estimated by the SC3-seq [log2 (RPM+1)]. Regression lines of representative samples are shown (MS01T05 and MS01T17 for 1 ng and
10 pg, respectively, of total RNAs). (B) Representative examples for correlations between the quantities of the ERCC RNAs spiked in a dilution series of
mESC total RNAs (MS01T01 andMS01T17 for 100 ng and 10 pg of total RNAs, respectively) and the estimated levels of the spike-in RNAs by the SC3-seq
[log2 (RPM+1)]. The SC3-seq data for the ERCC spike-in RNAs with more than 10 copies per 10 pg are used for the regression line. See Supplementary
Figure S3A for correlations in all samples. (C) Scatter-plot comparison of the SC3-seq [log2 (RPM+1)] between two independently amplified replicates
from 100 ng, 10 ng, 1 ng, 100 pg and 10 pg of mESC total RNAs. The white and yellow areas indicate expression-level ranges within 2-fold and 4-fold
differences between the replicates, respectively (also in (D) and (E)). Copy numbers per 10 pg of total RNAs estimated by the SC3-seq reads of the ERCC
spike-in RNAs in 100 ng of RNAs are indicated by dashed lines (red: 1000 copies; orange: 100 copies; pale blue: 10 copies; blue: 1 copy) (also in D–F). (D)
Scatter-plot comparison of the SC3-seq [log2 (RPM+1)] between a replicate from 100 ng of mESC total RNAs and a replicate from 10 ng, 1 ng, 100 pg and
10 pg of mESC total RNAs. (E) Scatter-plot comparison of the averaged SC3-seq data [log2 (RPM+1)] of 100 ng of mESC total RNAs (two replicates) with
those of 10 pg of RNAs (eight replicates). (F) Standard deviations (SDs) of gene-expression levels plotted against mean gene-expression levels by the SC3-
seq in the indicated eight 10-pg RNA samples. (G) Correlations in indicated comparisons [minimum (min) and maximum (max) correlation coefficients
(R2) are shown] and the percentages of genes within 2- and 4-fold expression differences in the indicated representative comparisons (all expression ranges
and genes expressed more than 20 copies per 10 pg of RNAs). (H) Total mRNA molecule numbers per 10-pg RNA estimated from the copy numbers of
the ERCC spike-in RNAs in 100 ng, 10 ng, 1 ng, 100 pg and 10 pg of mESC total RNAs.
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Figure 3. Coverage and accuracy of the SC3-seq. (A) Coverage of the SC3-seq from 10 pg of total RNAs as a function of the expression level [log2
(RPM+1)] in 100 ng of total RNAs. The black squares represent the means of coverage in single-sample analysis, with bars representing SDs. The results
of multiple-sample analyses under the definitions of detection where transcripts are detected in 1–8 of the eight amplified samples are represented by
squares with the indicated color codes. Copy numbers per 10 pg of total RNAs estimated by the SC3-seq reads of the ERCC spike-in RNAs in 100 ng
of RNAs are indicated by dashed lines (red: 1000 copies; orange: 100 copies; pale blue: 10 copies; blue: 1 copy). (B) Accuracy of the SC3-seq from 10 pg
of total RNAs as a function of the expression level [log2 (RPM+1)]. The representation code is the same as in (A). (C) The plot of the number of genes
detected [log2 (RPM+1)  4, fold changes of gene expression levels 2 in comparison to those determined by the full sequence reads (Supplementary
Table S1)] by the SC3-seq from 100 ng, 10 ng, 1 ng, 100 pg and 10 pg of mESC total RNAs (color code indicated) as a function of the sequence reads.
(D) The plot of the percentage of the detection [fold changes of gene expression levels 2 in comparison to those determined by the full sequence reads
(Supplementary Table S1)] by the SC3-seq from 10 pg of total RNAs as a function of the sequence reads, categorized by expression level ranges in 100 ng
of total RNAs (color code indicated).
we performed multiple sample analyses (eight samples were
analyzed), coverage was improved under the definitions of
detection where1 to5 of the eight amplified samples ex-
hibited reads (10 copies per 10-pg RNAs), whereas accu-
racy was essentially nearly 100% under all detection defini-
tions (Figure 3A and B). These findings indicate that a sin-
gle sample prepared by SC3-seq from single-cell level RNAs
exhibits excellent coverage and accuracy, and multiple sam-
ple analyses further improve both the coverage and accu-
racy.
Sequence reads required for the SC3-seq. One of the pro-
posed advantages of the SC3-seq is that it allows precise
quantification of gene expression with a relatively small
depth of sequence reads. Next, therefore, we went on to ex-
amine the number of reads that would be sufficient to accu-
rately determine gene-expression levels within from 100-ng
(10 000-cell level) to 10-pg (1-cell level) RNAs. We plotted
the number of genes with log2 (RPM+1) 4 ( 5 copies per
10-pg RNAs) that were detected accurately against the read
numbers [fold changes of gene expression levels2 in com-
parison to those determined by the full sequence reads (Sup-
plementary Table S1)]. As shown in Figure 3C, the number
of genes detected with [log2 (RPM+1)  4, fold changes of
gene expression levels 2] inRNAs from100 ng (10 000-cell
level) to 10 pg (1-cell level) by SC3-seq became saturated at
around 0.2 mega (M) mapped reads and that the detected
gene number was essentially identical in RNAs from 100
ng (10 000-cell level) to 100 pg (10-cell level) (∼7000) and
was smaller in 10-pg RNAs (1-cell level) (∼6000). We then
plotted the percentage of genes accurately detected by the
SC3-seq from 10 pg of total RNAs among genes detected
from 100 ng of total RNAs against the sequence reads, cat-
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Figure 4. Comparison of the performance of the SC3-seq with that of other single-cell RNA-seq methods. (A) Scatter-plot analysis of the correlation
between the expression level and the transcript length, detected by the SC3-seq [dilution samples from 100 ng (replicate 1, MS01T01), 10 ng (replicate 1,
MS01T05) and 10 pg (replicate 1, MS01T17) of ESC total RNAs, and a single mouse embryonic cell (MS04T18) and a single human iPSC (MS04T66)],
the Smart-seq2 [dilution samples from 1 ng (Smart-seq2 1ng, HEK rep1) and 10 pg (Smart-seq2 10 pg, HEK rep1) of HEK293 total RNAs, and a single
mouse embryonic fibroblast (Smart-seq2 MEF, rep 1)] (13), the single-cell RNA-seq by Yan et al. [a single human ESC (Yan hESC 1)] (34), and a full-
length RNA-seq [Ohta mESC and Ohta MEF (33)]. The expression levels by the SC3-seq are shown as log2 RPM, whereas those by the other methods
are shown as log2 FPKM. The histogram on the right of each scatter plot indicates the distribution of gene-expression levels of transcripts with different
length ranges (color code indicated). (B) Distributions of the mapped reads around the 3-prime ends of the transcripts by the three single-cell RNA-seq
methodologies. (C) Distributions of the mapped reads within the whole transcripts of different length ranges (color code indicated) by the three single-
cell RNA-seq methodologies. (D) Analysis for saturation of detection [gene-expression levels  the top 6555th and 6217th genes for mice and humans,
respectively (1/4 of all the annotated transcripts for mice and humans), ∼log2 RPM  3.69 ± 0.05 (SC3-seq), ∼log2 FPKM  2.21 ± 1.28 (Yan et al.)
and ∼log2 FPKM  2.92 ± 0.27 (Picelli et al.), fold changes of gene expression levels  2 in comparison to those determined by the full sequence reads
[Supplementary Table S1 or (13,34)] for all (top) and short (<1 kb, 913 and 832 genes for mice and humans, respectively) transcripts by the three single-cell
RNA-seq methodologies. See Supplementary Figure S4C for transcripts <750 bp and <500 bp.
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egorized by expression-level ranges [fold changes of gene ex-
pression levels2 in comparison to those determined by the
full sequence reads (Supplementary Table S1)] (Figure 3D).
This analysis also revealed that nearly all the genes with log2
(RPM+1)  6 ( 20 copies per 10-pg RNAs) and ∼60% of
genes with log2 (RPM+1) 4 ( 5 copies per 10-pg RNAs)
were detected in saturation by the SC3-seq from 10 pg of
total RNAs by around 0.2-M mapped reads (Figure 3D).
We therefore conclude that to identify genes expressed at a
substantial level [log2 (RPM+1)  4,  5 copies per 10-pg
RNAs] by SC3-seq, it should be sufficient to perform 0.2-M
mapped reads per sample, a substantially small number that
allows a highly parallel sequencing of numerous samples.
Comparison of the performance of SC3-seq with that of other
typical methods
Wenext compared the quantitative performance of the SC3-
seq with that of other typical methods for single-cell RNA
seq (9,10,13,34).
First, we compared the reproducibility of the transcript
measurements in diluted RNAs by the SC3-seq with that by
the Smart-seq2 (13) [the manuscripts by (9,10,34) did not
examine the reproducibility of their method using a dilu-
tion series of RNAs]. As shown in Supplementary Figure
S4A and B, the maximum and minimum correlation coeffi-
cients (R2) of the transcriptmeasurements in 10 pg ofRNAs
by the SC3-seq among 16 replicates were 0.689 and 0.659,
respectively, whereas the correlation coefficient (R2) of the
two replicates [only two replicates of 10 pg of RNAs were
analyzed by (13)] by the Smart-seq2was 0.613. Indeed, in all
starting amounts of RNAs/in all pairs of comparisons, the
maximum and minimum correlation coefficients (R2) of the
transcript measurements by the SC3-seq were higher than
those by the Smart-seq2 (Supplementary Figure S4A and
B). These data strongly suggest that the SC3-seq shows su-
perior reproducibility to the Smart-seq2.
Second, we examined the relationship between the esti-
mated expression level and the transcript length in sam-
ples prepared by the SC3-seq and the other methods, and
as a control, in the published RNA-seq data prepared
from a large quantity of RNAs of mESCs and mouse em-
bryonic fibroblasts (MEFs) with massive sequence depth
(33). As shown in Figure 4A (panels at bottom right), the
control samples exhibited a highly diverse distribution of
expression-level ranges irrespective of the transcript lengths
and cell types (Ohta mESCs and Ohta MEFs), and the av-
erage expression levels were similar among all transcript
lengths [the modes of expression levels are around log2
FPKM (fragment per kilobase per million mapped reads)
= 2]. Remarkably, the distribution of the expression-level
ranges as a function of the transcript length detected by the
SC3-seq for 100 ng, 1 ng and 10 pg of ESC RNAs as well as
for single embryonic or cultured cells (see below) was very
similar to that by the control RNA-seq (Figure 4A, pan-
els in the upper rows): the genes show relatively constant
expression levels irrespective of their transcript length, i.e.
the modes of the expression levels are similar (around log2
RPM = 4) throughout all the transcript lengths. This find-
ing indicates that the SC3-seq correctly reflects the represen-
tation of gene expression across all transcript-length ranges
from a single-cell level starting material.
In contrast, both the results provided by Picelli et al. for
1 ng and 10 pg of RNAs from HEK293 cells and for sin-
gle MEFs [Smart-seq2, (13)] and those reported by Yan
et al. for single human (h) ESCs [a method that mod-
ified and adapted our amplification procedure for full-
length RNA-seq, (9,10,34)] revealed a similar trend, which
is markedly different from that by the SC3-seq and the
control RNA-seq: the modes of expression levels vary de-
pending on the transcript length (e.g. the modes of ex-
pression levels of longer genes were lower and those of
shorter genes were higher) (Figure 4A, panels at bottom,
two left columns), possibly due to the low efficiency of the
synthesis/amplification for longer transcripts, which altered
the representation of the original gene expression.
We next examined the differences of the read positions
across the transcripts among the SC3-seq and the other
single-cell RNA seqmethods. As shown in Figure 4B andC,
the SC3-seq exhibited a clear sharp peak exclusively at the
very 3-prime ends of the transcripts across all the transcript-
length ranges, as described in part above (Figure 1). Con-
versely, the other two methodologies, which should theo-
retically generate reads across the transcript length in a uni-
formmanner, unexpectedly resulted in reads with somewhat
non-uniform distribution along the transcripts and with a
skew toward the 3-prime (Yan et al.) or 5-prime (Picelli
et al.) ends, especially for longer transcripts (Figure 4C).
In accordance with these findings, we found that whereas
the SC3-seq requires∼0.2Mofmapped reads for saturation
of the correct detection of short (<1 kb) transcripts [gene-
expression levels the top 6555th gene (the number corre-
sponding to 1/4 of all the annotated transcripts in mice),
∼log2 RPM  3.69 ± 0.05, fold changes of gene expres-
sion levels  2 in comparison to those determined by the
full sequence reads (Supplementary Table S1)], the other
two methods require more than ∼2 M of mapped reads for
saturation of the correct detection of such transcripts [<1
kb, gene-expression levelsthe top 6555th and 6217th gene
(the number corresponding to 1/4 of all the annotated tran-
scripts in mice and humans, respectively), ∼log2 FPKM 
2.92 ± 0.27 (13) or 2.21 ± 0.05 (34), fold changes of gene
expression levels  2 in comparison to those determined
by the full sequence reads (13,34)] (Figure 4D and Supple-
mentary Figure S4C). Taken together, these results demon-
strate that SC3-seq is a more quantitative and efficient tech-
nique for single-cell transcriptome analysis than the other
two typical methods.
Application of the SC3-seq to developmental/stem cell biol-
ogy
Identification of genes that distinguish cell types in peri-
implantation mouse blastocysts. The peri-implantation
mouse blastocysts at embryonic day (E) 4.5 consist of at
least three distinct cell types: the epiblasts, the primitive en-
doderm (PE) and the trophectoderm (TE) (40). The former
two cell types make up the ICM. Based on the anatomical
location, the TE can be classified into two types: the polar
(p) TE, which directly contacts the ICM and subsequently
forms extra-embryonic ectoderm (ExE) and ectoplacental
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cones, and the mural (m) TE, which is located at the ab-
embryonic part of the blastocysts and later forms primary
trophoblast giant cells (41,42). There has been no report ex-
ploring whether global gene-expression differences exist be-
tween pTE and mTE at E4.5. To demonstrate the capacity
of the SC3-seq to address biologically relevant questions, we
first went on to determine whether the SC3-seq successfully
discriminates cell-type differences in the blastocysts.
We isolated peri-implantation blastocysts at E4.5 (Sup-
plementary Figure S5A), bisected them into embryonic (po-
lar with ICM) and ab-embryonic (mural) parts, carefully
dissociated them into single cells, picked up single cells that
are considered to compose mTE or pTE/ICM and ampli-
fied their cDNAs. We examined the amplification efficiency
of cDNAs by analyzing the expression level of Gapdh and
the ERCC spike-in RNAs (Supplementary Figure S5B and
C), roughly classified the cDNAs by analyzing the expres-
sion of the key markersNanog (epiblast),Gata4 (PE),Cdx2
(TE) and Gata2 (TE) (Supplementary Figure S5B), and
among 67 single-cell cDNAs with good quality, processed
37 representative cDNAs [12 for mTE, seven for m/pTE,
nine for epiblasts, nine for PE by their anatomical location
and marker expression; we noted that many of the Gata2-
positive TE lacked Cdx2 mRNA expression at this stage,
although nearly all the TE showed CDX2 protein by IF
staining (Supplementary Figure S5A and B)] for the SC3-
seq analysis (Supplementary Figure S5D). UHC revealed
that these cells are classified largely into two clusters, both of
which are further divided into two sub-clusters (Figure 5A).
The one major cluster consists of two sub-clusters repre-
senting, based on the expression of key signature genes, the
epiblasts and the PE (Fgf4, Nanog, Sox2 and Klf2 for the
epiblasts andGata4, Pdgfra, Sox17, Sox7 andGata6 for the
PE) (Figure 5B). Among the cells in the other major cluster,
nine out of 12mTE (cells we isolated from the ab-embryonic
parts) were classified into a single sub-cluster and the three
remaining such cells were classified into the neighboring
sub-cluster, with,most likely, pTEbymarker expression and
anatomical location. Accordingly, pair-wise comparisons of
correlation coefficients (R2) of all single cells demonstrated
a close relationship betweenmTE and pTE (Supplementary
Figure S5E). Consistent with the UHC analysis, the PCA
also classified the cells into four distinct groups (Figure 5C).
These findings demonstrate that the SC3-seq successfully
identifies the distinct cell types present in developing em-
bryos and that mTE and pTE exhibit/initiate differential
gene expression at a global level as early as E4.5.
To further validate the power of the SC3-seq, we went on
to identify genes that are differentially expressed between
the epiblasts and the PE [we define the DEGs as those ex-
hibiting differences in their average expression levels of4-
fold, log2 values (RPM+1) of 4 and FDR of <0.01 based
on oneway analysis of variance (ANOVA)]. Consistent with
previous findings, genes up-regulated in the epiblasts (309
genes) included Tdgf1, Utf1, Sox2 and Nanog and were en-
riched with GO terms such as ‘regulation of transcription’,
‘negative regulation of gene expression’ and ‘negative regu-
lation of macromolecule metabolic process’, whereas genes
up-regulated in the PE (504 genes) included Sparc, Lama1,
Lamb1, Lamc1, Gata4, Gata6 and Pdgfra, and were en-
riched with GO terms such as ‘lipid biosynthetic process’,
‘glycerolipid metabolic process’ and ‘embryonic develop-
ment ending in birth or egg hatching’ (Figure 5D and Sup-
plementary Figure S5F and G).
We next explored the genes that are differentially ex-
pressed between pTE and mTE. There has been no sys-
tematic analysis of global gene expression of these two cell
types. We identified 231 genes that are up-regulated in pTE,
which include Hspd1, Ddah1, Gsto1 and Utf1, and are en-
riched with cell cycle-related GO terms such as ‘cell cycle
phase’, ‘M phase’ and ‘mitotic cell cycle’ (Figure 5D and
F). We noted that the genes up-regulated in pTE in com-
parison to mTE were expressed in the epiblasts and the
PE at similar levels to that in pTE (Figure 5E), indicat-
ing that these genes are specifically down-regulated in mTE
in the blastocysts. On the other hand, we identified 391
genes that are up-regulated in mTE, which include Slc2a3,
Dmkn, Klf5, Gata2 and Dppa1, and are enriched with GO
terms such as ‘vitamin transport’, ‘PDGFR signaling path-
way’, ‘lipid storage’, ‘embryonic placenta development’ and
‘membrane organization’ (Figure 5D andF). These data are
consistent with the idea that as early as E4.5, mTE specifi-
cally stops or slows down the mitotic cell cycle and takes on
an end-replication pathway for differentiation into primary
trophoblast giant cells.
We calculated the average copy numbers of the genes in
each cell type and found that single mTE cells bear more
abundant transcripts (∼2-fold) than single epiblast cells,
PE cells and pTE cells (Figure 5G), further supporting the
idea that mTE initiates an end-replication to bear a larger
amount of transcripts compared to typical single cells at this
embryonic stage. Thus, when used together with the ERCC
spike-in RNAs, the SC3-seq allows a precise estimation of
transcript levels in single cells.
Heterogeneity of hiPSCs under different culture conditions.
We next examined whether the SC3-seq successfully detects
the heterogeneity of gene expression in seemingly homo-
geneous cell populations. We thus measured the gene ex-
pression of hiPSCs cultured on feeder cells (on-feeder hiP-
SCs) and in hiPSCs cultured under a feeder-free condition
(feeder-free hiPSCs). For this purpose, we generated single-
cell cDNAs of two lines of hiPSCs (585A1 and 585B1) cul-
tured on the SNL feeder cells and cultured under a feeder-
free condition (in total we generated 112 single-cell cDNAs
of good quality) (Figure 6A and Supplementary Figure S6A
and B) (23,25,26) and performed an SC3-seq analysis of the
representative cells (seven, seven, eight and seven single cells
for on-feeder 585A1, on-feeder 585B1, feeder-free 585A1
and feeder-free 585B1, respectively) (Supplementary Figure
S6C). TheUHCanalysis revealed that the on-feeder hiPSCs
and the feeder-free hiPSCs could be classified essentially
into two distinct clusters irrespective of the line difference,
with the exception that one on-feeder hiPSC was classified
into the feeder-free cluster and one feeder-free hiPSC was
classified into the on-feeder cluster (Figure 6B and Supple-
mentary Figure S6D). This indicated the distinct, although
still very similar, properties of the on-feeder and feeder-
free hiPSCs. Interestingly, the PCA analysis showed that the
feeder-free hiPSCs, except in the case of the two outliers,
were clustered tightly together, whereas the on-feeder hiP-
SCs weremore scattered, especially along the PC2 axis (Fig-
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Figure 5. Analysis of E4.5 blastocysts by the SC3-seq. (A, B) Unsupervised hierarchical clustering (UHC) with all expressed genes [log2 (RPM+1)  4 in
at least one sample, 12 010 genes] (A) and heat map representation of the expression levels of several marker genes for the epiblast, the primitive endoderm
(PE) and the trophectoderm (TE) (B). The locations of the isolated cells (embryonic or ab-embryonic) are indicated between the clustering tree and the
heat map. The annotated cell types [epiblast, PE, polar (p) TE and mural (m) TE] are defined based on the clustering, the locations of the isolated cells and
known marker gene expression. (C) Principal component analysis (PCA) of all cells by all expressed genes. The cells [colored according to the clustering
groups in (A)] are plotted in two-dimensional space defined by PC1 and PC2 (top) or by PC1 and PC3 (bottom). (D) Scatter-plot analysis of the averaged
gene-expression differences between the epiblast (nine samples) and the PE (nine samples) (left), and between the mTE (nine samples) and the pTE (10
samples) (right). The differentially expressed genes are defined as those showing a more than 4-fold difference in expression (franking diagonal lines) in
one cell type with mean log2 (RPM+1)  4. The genes defined as up-regulated in the PE (504 genes), the epiblast (309 genes), the pTE (231 genes) and
the mTE (391 genes) are colored blue, green, yellow and orange, respectively. Key marker genes for each cell type are indicated. (E) The box-plot analysis
of the expression levels of the genes up-regulated in mTE (left) or pTE (right) among the four cell types. The bar in the middle of the box indicates the
median expression level, and the top and bottom edges of the box, and the top and bottom bars indicate the expression levels encompassing expression of
50% and ±2 SDs from the median of the genes, respectively (also in (G)). (F) Gene ontology (GO) analysis of the genes up-regulated in mTE (top) or pTE
(bottom) using GO BP FAT collection (35). (G) The box-plot analysis of the average gene-expression levels, calculated based on the copy numbers of the
ERCC spike-in RNAs, in the four cell types.
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Figure 6. Analysis of gene expression of hiPSCs cultured with or without feeder cells. (A) Representative phase-contrast images of the hiPSC colonies
(585B1) cultured with the SNL feeder cells (top) or without feeder free cells (bottom). Bar, 200 m. (B) UHC with all expressed genes [log2 (RPM+1)  4
in at least one sample, 12 406 genes] (top) and heat map representation of the expression levels of genes that show highly heterogeneous expression in cells
under feeder-free conditions (PKIB and SCGB3A2), under on-feeder conditions (SFRP1 and AMOTL2) and under both sets of conditions (ZFP42 and
ANXA3). The expression levels of POU5F1 and NANOG are also shown as examples of genes with small fluctuation. (C) PCA of all cells by all expressed
genes. The cells (color code indicated) are plotted in two-dimensional space defined by PC1 and PC2. (D) Gene expression heterogeneity in single on-feeder
and feeder-free hiPSCs analyzed by plotting the maximum expression level among the group (except the outliers, MS04T72, MS04T67 and MS04T78, as
shown in (C)) against standard deviations (SDs). Genes that show the max expression level  6 and SD  2 are considered to be highly heterogeneously
expressed genes [699 genes (yellow) in on-feeder hiPSCs and 61 genes (blue) in feeder-free hiPSCs]. (E) Venn diagram showing the relationship among
the highly heterogeneously expressed genes identified in (D). (F) Scatter plot of the SDs of gene expression levels in on-feeder hiPSCs and in feeder-free
hiPSCs. The genes are colored as in (D) and those that are highly heterogeneous under both conditions (20 genes) are colored red.









PAGE 15 OF 17 Nucleic Acids Research, 2015, Vol. 43, No. 9 e60
ure 6C), indicating that the gene expression of the on-feeder
hiPSCs was more heterogeneous than that of the feeder-free
hiPSCs.
To examine this point further, we plotted the SDs of
the gene-expression levels against the gene-expression lev-
els in the on-feeder and feeder-free hiPSCs. Consistent with
the PCA analysis, this analysis indicated that the on-feeder
hiPSCs showed higher SDs of gene-expression levels than
the feeder-free iPSCs in essentially all the gene-expression
ranges: we identified 699 genes that bear a maximum ex-
pression level log2 (RPM+1)  6 among the cells analyzed
and the SDs 2 in the on-feeder iPSCs, and only 61 such
genes in the feeder-free hiPSCs (Figure 6D). We then plot-
ted the SDs of the gene-expression levels of the feeder-free
iPSCs against those of the on-feeder hiPSCs and identi-
fied 41 genes with higher SDs in the feeder-free hiPSCs,
including PK1B, SNHG12, SCGB3A2, LDOC1, MTHFS
andRBM14/RBM4, 20 genes with high SDs (SDs2) both
in the feeder-free and on-feeder hiPSCs, including ZFP42,
ANXA3, LEFTY1, PTCD1 and KDR, and 679 genes with
higher SDs in the on-feeder hiPSCs, including AMOTL2,
LEFTY2, ANXA1, SGK1, CTGF and SFRP1 (Figure 6B,
E and F). Collectively, these findings demonstrate that the
feeder-free hiPSCs are more homogeneous in gene expres-
sion than the on-feeder hiPSCs. We conclude that the SC3-
seq is a powerful methodology that can identify the pres-
ence of heterogeneity in gene expression within seemingly
homogeneous cell populations.
DISCUSSION
We have here presented a novel single-cell RNA-seq
methodology, the SC3-seq, which synthesizes, amplifies and
reads the very 3-prime ends of cDNAs from single-cell
RNAs, allowing highly quantitative and parallel measure-
ments of single-cell gene expression with a relatively small
sequence depth. Since the SC3-seq reads only the very 3-
prime ends of mRNAs, this method is not suitable for appli-
cations that seek to identify specific splice variants in single
cells. It may also be relatively difficult to discriminate allelic
expression by the SC3-seq, unless there are allelic single nu-
cleotide polymorphisms around ∼200 bp from the TTSs.
However, a primary objective of single-cell gene expression
analysis is to identify genes that show specific expression in
relevant cells or to identify gene-expression heterogeneity
among relevant cell populations. Compared to other single-
cell RNA-seq methods that aim to generate, amplify and
read full-length cDNAs, the SC3-seq exhibits a superior
quantitative performance in that it does not underestimate
the expression levels of relatively longer transcripts (Figure
4A) and it detects much larger numbers of transcripts with
smaller sequence depth (Figure 4D). We therefore consider
the SC3-seq a powerful strategy for such primary applica-
tions.
We provided evidence that the SC3-seq allows a highly
reproducible/quantitative RNA-seq with a wide range of
starting amounts of RNAs [from 100 ng (10 000-cell level)
to 10 pg (1-cell level)] by applying differing numbers of am-
plification cycles of PCR for the preparation of initial cD-
NAs (Figure 2). Indeed, the reproducibility of the SC3-seq
for the starting materials from 10 000 cells to as little as 10
cells is extremely high (R2  0.940) (Figure 2). The SC3-
seq is therefore a versatile methodology suitable not only
for single-cell gene expression analysis but also for analysis
of the gene expression in materials prepared from a rela-
tively large number of cells with similar properties, such as
the developing epiblasts or cell populations expressing com-
mon markers sorted by fluorescent-activated cell sorting.
We consider that the decline in the correlation for the
SC3-seq with 1-cell level RNAs (10 000-cell level versus 1-
cell level: R2 = 0.776–0.797; 1-cell level versus 1-cell level:
R2 = 0.677–708) (Figure 2), although still a good correla-
tion, may have been partly attributable to a stochastic loss
of RNAs with low expression levels during the preparation
of the dilution samples. Our reasoning is as follows. First,
the correlation is higher for RNAs expressed at substan-
tial levels (e.g. more than ∼20 copies/10-pg RNAs) (Figure
2). Second, the correlation coefficient between the SC3-seq
for 10 000 cell-level RNAs and for 1-cell level RNAs (R2 =
0.776–0.797) is substantially higher than that between two
independent SC3-seq analyses for 1-cell level RNAs (R2 =
0.677–708). Indeed, we have evidence that amplification by
SC3-seq from 10-pg RNAs of genes expressed at low lev-
els (e.g. less than ∼20 copies/10-pg RNAs) results either in
representative or no amplification, the latter being presum-
ably mainly due to the loss of transcripts during dilution
(data not shown). We therefore propose that the SC3-seq is
a highly representative protocol for single-cell gene expres-
sion analysis.
Accordingly, we applied the SC3-seq to address two bi-
ological issues: decomposition of the cell types in the E4.5
mouse blastocysts and identification of cellular heterogene-
ity of hiPSCs cultured under different conditions (Figures
5 and 6). For the former issue, we successfully identified
four distinct cell types that comprise the blastocysts and
their global gene-expression differences. The identification
of genes that are up-regulated in E4.5 epiblasts in compar-
ison to the PE will be critical to understand the mecha-
nism for epiblast formation, a primed state for differenti-
ation into three germ layers. Furthermore, to our knowl-
edge, the present work is the first to identify the global gene-
expression differences between the pTE, precursors for the
extraembryonic ectoderm and the mTE, precursors for the
primary trophoblast giant cells. Our analysis revealed that
the mTE exhibited a gene expression profile indicative of
the cessation/slow-down of the mitotic cell cycle and of dif-
ferentiation into primary trophoblast giant cells (42) and a
larger amount of total transcript levels in comparison to the
other three cell types in the blastocysts, indicating that the
E4.5 mTE cells are starting differentiation into primary tro-
phoblast giant cells with their characteristic end-replication
cycles. Our study thus also provides a foundation for under-
standing the mechanism of the formation of primary tro-
phoblast giant cells.
With respect to the latter issue, remarkably, we showed
that the single on-feeder hiPSCs exhibited much higher het-
erogeneity in gene expression than the single feeder-free hiP-
SCs: we identified 699 genes that expressed log2 (RPM+1)
values of6 (maximum level among the cells analyzed) and
bore SDs of gene expression levels among different single
cells of 2 in the on-feeder hiPSCs, whereas we detected
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only 61 such genes in the feeder-free hiPSCs (Figure 6).
Since the feeder-free hiPSCs are less heterogeneous, which
would be better for homogeneous differentiation, our find-
ings indicate they are not only useful in culture, but would
also be a superior starting material for a more uniform dif-
ferentiation toward lineages of interest.Notably, under both
conditions, ZFP42, a gene known to be expressed in naı¨ve
but not primed epiblast cells in mice and to show hetero-
geneity in mESCs cultured with serum (43), was one of
themost heterogeneously expressed genes. Considering that
ZFP42 is expressed at a high level in the ICM of the hu-
man pre-implantation blastocysts (ZFP42 is also expressed
in TE and PE in humans) (34), this finding may indicate
that hiPSCs are, to some extent, fluctuating between a naı¨ve
and a primed state. Further studies, including those clari-
fying the functions of the relevant genes, are necessary to
more precisely determine the properties of hiPSCs/ESCs.
In conclusion, we have established the SC3-seq and demon-
strated its capacity to address biologically important ques-
tions. Based on our findings, we propose that SC3-seq is one
of the most practical approaches for single-cell gene expres-
sion analysis in biologically relevant contexts.
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